Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heme regulation of the activity of diverse proteins was thought to be mediated by heme-responsive motifs (HRMs). The yeast
transcriptional activator
Hap1 contains seven HRMs:
HRM1
-7. Three copies of a 17-amino-acid repeat are also located in the region encompassing
HRM1
to -6. We examined the effects of these HRMs and repeats on heme regulation of Hap1 activity by deletion analysis and by Ala substitutions of key residues. We found that the effect of mutation or deletion of one HRM or 17-amino-acid repeat on Hap1 heme responsiveness is different from the effect of mutation or deletion of another HRM or repeat. Our data suggest that HRM7 plays a dominant role in mediating heme activation of Hap1 in heme-sufficient cells while
HRM1
-6 may scavenge heme and cause a low level of Hap1 activation in heme-deficient cells. These results may help in understanding the roles of HRMs in other hemoproteins.
...
PMID:Functional analysis of heme regulatory elements of the transcriptional activator Hap1. 1087 49
Beta-catenin (CTNNB1) directs ectodermal appendage spacing by activating
ectodysplasin A receptor
(
EDAR
) transcription, but whether CTNNB1 acts by a similar mechanism in the prostate, an endoderm-derived tissue, is unclear. Here we examined the expression, function, and CTNNB1 dependence of the
EDAR
pathway during prostate development.
In situ
hybridization studies reveal
EDAR
pathway components including
Wnt10b
in the developing prostate and localize these factors to prostatic bud epithelium where CTNNB1 target genes are co-expressed. We used a genetic approach to ectopically activate CTNNB1 in developing mouse prostate and observed focal increases in
Edar
and
Wnt10b
mRNAs. We also used a genetic approach to test the prostatic consequences of activating or inhibiting
Edar
expression.
Edar
overexpression does not visibly alter prostatic bud formation or branching morphogenesis, and
Edar
expression is not necessary for either of these events. However,
Edar
overexpression is associated with an abnormally thick and collagen-rich stroma in adult mouse prostates. These results support CTNNB1 as a
transcriptional activator
of
Edar
and
Wnt10b
in the developing prostate and demonstrate
Edar
is not only important for ectodermal appendage patterning but also influences collagen organization in adult prostates.This article has an associated First Person interview with the first author of the paper.
...
PMID:Edar is a downstream target of beta-catenin and drives collagen accumulation in the mouse prostate. 3074 37